Related Experiment Video
Updated: Nov 25, 2025
07:35
Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
11.7K
MicroRNAs and Polycystic Kidney Disease
1Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Kidney Medicine
|December 15, 2020
Summary
MicroRNAs show promise in treating polycystic kidney diseases, moving beyond supportive care. These noncoding RNAs offer new therapeutic targets and diagnostic biomarkers for polycystic kidney diseases.
Area of Science:
- Biochemistry
- Genetics
- Nephrology
Background:
- Polycystic kidney diseases (PKDs) management is evolving from supportive care to disease-modifying therapies.
- Noncoding RNAs, specifically microRNAs, are increasingly recognized for their role in PKD pathogenesis.
- MicroRNAs regulate gene expression, impacting key genes like PKD1 and PKD2 involved in PKD development.
Purpose of the Study:
- To review the current understanding of microRNA functions in the pathogenesis of polycystic kidney diseases.
- To highlight the potential of microRNAs as therapeutic targets and biomarkers for PKDs.
- To provide a foundation for exploring microRNA-based disease-modifying treatments.
Main Methods:
- Narrative review of existing literature on microRNAs and polycystic kidney diseases.
- Analysis of studies investigating microRNA involvement in PKD gene regulation.
- Examination of preclinical and clinical data for microRNA-targeted therapies.
Main Results:
- MicroRNAs play a significant role in regulating genes central to PKD pathogenesis.
- Seminal studies indicate microRNAs' potential as diagnostic and prognostic biomarkers for PKDs.
- Therapeutic strategies targeting microRNAs, such as anti-miR-17 and anti-miR-21, are progressing in development.
Conclusions:
- MicroRNAs represent a promising frontier for novel targeted therapies in polycystic kidney diseases.
- Further research and clinical trials are expected to yield new microRNA-based drugs for PKDs.
- Understanding microRNA mechanisms is crucial for developing effective disease-modifying treatments for PKDs.
Related Concept Videos
01:10Nephrons
5.2K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
5.2K
01:20Renal Corpuscle
5.8K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
5.8K
01:25Chronic Kidney Disease I: Introduction
362
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
362
01:24Nephrotic Syndrome I : Introduction
281
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
281
01:28Chronic Kidney Disease III: Interprofessional Care
213
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
213
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
148
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
148